Free Trial

Lance Wilkes Analyst Performance

Analyst at Sanford C. Bernstein

Lance Wilkes is a stock analyst at Sanford C. Bernstein in the medical sector, covering 8 publicly traded companies. Over the past year, Lance Wilkes has issued 7 stock ratings, including buy and hold recommendations. While full access to Lance Wilkes' proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Lance Wilkes' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 7 Years
Buy Recommendations
50.00% 5 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%5 ratings
Hold40.0%4 ratings
Sell10.0%1 ratings

Out of 10 total stock ratings issued by Lance Wilkes at Sanford C. Bernstein, the majority (50.0%) have been Buy recommendations, followed by 40.0% Hold and 10.0% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
87.5% of companies on NYSE
7 companies
NASDAQ
12.5% of companies on NASDAQ
1 company

Lance Wilkes, an analyst at Sanford C. Bernstein, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
100.0%

Lance Wilkes of Sanford C. Bernstein specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED - HMO
5 companies
62.5%
MEDICAL SERVICES
2 companies
25.0%
DRUG STORES & PROPRIETARY STORES
1 company
12.5%

Lance Wilkes' Ratings History at Sanford C. Bernstein

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CVS Health Corporation stock logo
CVS
CVS Health
9/5/2025Boost Price Target$73.83$77.00Market Perform
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
9/5/2025Boost Price Target$314.04$379.00Outperform
Molina Healthcare, Inc stock logo
MOH
Molina Healthcare
9/5/2025Lower Price Target$172.79$220.00Outperform
Humana Inc. stock logo
HUM
Humana
9/5/2025Boost Price Target$310.95$341.00Outperform
Centene Corporation stock logo
CNC
Centene
9/5/2025Lower Price Target$28.65$36.00Outperform
Agilon Health, Inc. stock logo
AGL
Agilon Health
8/20/2025Reiterated Rating$1.25$1.40Market Perform
Molina Healthcare, Inc stock logo
MOH
Molina Healthcare
4/22/2025Initiated Coverage$301.66$414.00Outperform